Chlorpheniramine maleate

CAS No. 113-92-8

Chlorpheniramine maleate( Chlorprophenpyridamine (maleate) | dl-Chlorpheniramine (maleate) )

Catalog No. M10490 CAS No. 113-92-8

Chlorpheniramine (Chlorpheniramine maleate, Chlorphenamine) is an histamine H1 receptor antagonist .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Chlorpheniramine maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Chlorpheniramine (Chlorpheniramine maleate, Chlorphenamine) is an histamine H1 receptor antagonist .
  • Description
    Chlorpheniramine (Chlorpheniramine maleate, Chlorphenamine) is an histamine H1 receptor antagonist .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Chlorprophenpyridamine (maleate) | dl-Chlorpheniramine (maleate)
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1 receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    113-92-8
  • Formula Weight
    390.87
  • Molecular Formula
    C20H23ClN2O4
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 78 mg/mL (199.55 mM); Water: 78 mg/mL (199.55 mM); DMSO: 78 mg/mL (199.55 mM)
  • SMILES
    CN(CCC(C1=CC=CC=N1)C2=CC=C(Cl)C=C2)C.O=C(O)/C=C\C(O)=O
  • Chemical Name
    3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Iemura R, et al. J Med Chem, 1986, 29(7), 1178-1183.
molnova catalog
related products
  • Alcaftadine

    A H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis.

  • Deguelin

    Deguelin is a PI3K/AKT Inhibitor, which is a natural product isolated from plants in the Mundulea sericea family.

  • MK-0249

    MK-0249 is a novel potent, selective histamine H3 inverse agonist for the treatment of cognitive impairment with schizophrenia.